Skip to content
Sexuality – Lifestyle
Author:
Korro Bio, Inc.
Korro to Present at the 2026 Jefferies Global Healthcare Conference
May 27, 2026
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
May 19, 2026
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 15, 2026
←
Previous Page
1
2